Massivemarkets

COR

Cencora, Inc.

NYSE · usd

$331.00-7.48 (-2.21%)
As of 4:39:53 PM EDT on Oct 23, 2026 · 15-minute delayed

Cencora, Inc. (COR) trades at $331.00 (-2.21%) as of 4:39:53 PM EDT on Oct 23, 2026, +6.82% over the past month. Market cap is $64.59B, with 2.9 days to cover in short interest.

Stock performance

How Cencora, Inc. (COR) stock has performed from one day to one year, with its 52-week range.

-1.45%
-$4.88 over 1D
$331.19$332.76$334.34$335.919:30 AM11:10 AM12:45 PM2:25 PM4:00 PM$331.00
1D
-2.21%
1W
-2.91%
1M
+6.82%
YTD
-2.00%
1Y
-0.51%
52-wk range
$244.82 – $377.54

Key statistics

Today's trading snapshot for COR: day range, open, previous close, volume and market cap.

Day range
$330.31 – $338.07
Open
$337.15
Prev close
$338.48
Volume
1.17M
Market cap
$64.59B
Shares out
190.83M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Cencora, Inc.: P/E, P/S, P/B, ROE and more.

P/E
24.61
P/S
0.19
P/B
21.17
P/FCF
15.91
ROE
86.0%
ROA
3.1%
Debt/Equity
3.84
Div yield
0.72%

As of Oct 22, 2026

8-K filings

Material corporate events Cencora, Inc. has disclosed to the SEC on Form 8-K.

  • Deal agreementsOct 21, 2026

    On October 21, 2026, the Company issued a news release announcing that it has entered into an Agreement and Plan of Merger, dated as of October 20, 2026, by and among the Company, Dolphins Merger Sub, Inc.... and American Oncology Network, Inc.... pursuant to which... Merger Sub will merge with and into AON... with AON surviving the Merger as a wholly-owned subsidiary of the Company.

  • Board of directorsSep 25, 2026

    On September 24, 2026, the Board of Directors (the "Board") of Cencora, Inc. (the "Company") appointed Robert E. Sanchez to serve on the Board (the "Appointment"), effective October 1, 2026 (the "Effective Date"). In connection with the Appointment, the Board increased from ten to eleven members in accordance with the Company's Amended and Restated Bylaws.

  • Board of directorsAug 14, 2026

    On August 13, 2026, following the conclusion of the quarterly meeting of the Board of Directors (the "Board") of Cencora, Inc. (the "Company"), Lorence H. Kim, M.D., informed the Company of his intent to resign from the Board effective immediately. Dr. Kim's decision was made in connection with his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc. and his need to devote additional time to his professional responsibilities at that company.

  • Guidance and outlookAug 12, 2026

    Cencora is reaffirming its previously issued adjusted diluted EPS guidance range of $17.75 to $17.95 for fiscal year 2026.

  • Debt activityAug 5, 2026

    The Receivables Securitization Facility is available to provide additional liquidity and funding for the ongoing business needs of the Company and its subsidiaries. Availability under the Receivables Securitization Facility is based on the accounts receivables originated by ABDC and ASD Specialty Healthcare, LLC ("ASD") from the sale of pharmaceuticals and other related products and services. Pursuant to the Receivables Securitization Facility, ABDC and ASD sell their accounts receivable to ARFC. ARFC may sell interests in the accounts receivables purchased from ABDC and ASD to the various purchaser groups party to the receivables securitization facility.

Dividend history and stock splits

Cencora, Inc.'s recent dividend payments and stock splits.

Dividends

  • $0.60ex-div Aug 14, 2026
  • $0.60ex-div May 15, 2026
  • $0.60ex-div Feb 13, 2026
  • $0.60ex-div Nov 14, 2025

Splits

No recent splits.

COR short interest

How heavily COR is shorted: shares short, days to cover and average daily volume.

Days to cover
2.9
Short interest
3.92M
Avg volume
1.37M

As of · reported to FINRA twice monthly.

COR news

The latest news and headlines about Cencora, Inc. (COR).

Frequently asked questions

What is the Cencora, Inc. (COR) stock price today?

Cencora, Inc. (COR) is trading at $331.00 (-2.21% on the day) as of 4:39:53 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Cencora, Inc.?

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers.

What is the short interest in COR?

As of Sep 30, 2026, COR has 3.92M shares short and 2.9 days to cover.

Does Cencora, Inc. (COR) pay a dividend?

Yes. Cencora, Inc. (COR)'s most recent dividend was $0.60 per share, with an ex-dividend date of Aug 14, 2026. Full COR dividend history is available from the Massive API.

What exchange is COR listed on?

Cencora, Inc. (COR) trades on NYSE in USD, in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES industry.

Build with AI

Build an analysis of COR with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a COR analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.